These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28916403)

  • 21. Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency.
    Rodríguez-Gutiérrez PG; Colima-Fausto AG; Zepeda-Olmos PM; Hernández-Flores TJ; González-García JR; Magaña-Torres MT
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.
    Pruneta-Deloche V; Marçais C; Perrot L; Sassolas A; Delay M; Estour B; Lagarde M; Moulin P
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3995-8. PubMed ID: 15840743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.
    Wilson DE; Hata A; Kwong LK; Lingam A; Shuhua J; Ridinger DN; Yeager C; Kaltenborn KC; Iverius PH; Lalouel JM
    J Clin Invest; 1993 Jul; 92(1):203-11. PubMed ID: 8325986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
    Overgaard M; Brasen CL; Svaneby D; Feddersen S; Nybo M
    Ann Clin Biochem; 2013 Jul; 50(Pt 4):374-9. PubMed ID: 23761384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed analysis of lipolytic enzymes in a Japanese woman of familial lipoprotein lipase deficiency - Effects of pemafibrate treatment.
    Minamizuka T; Kobayashi J; Tada H; Miyashita K; Koshizaka M; Maezawa Y; Ono H; Yokote K
    Clin Chim Acta; 2020 Nov; 510():216-219. PubMed ID: 32682802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.
    Paquette M; Hegele RA; Paré G; Baass A
    J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound but non-linked heterozygous p.W14X and p.L279 V LPL gene mutations in a Chinese patient with long-term severe hypertriglyceridemia and recurrent acute pancreatitis.
    Li X; Yang Q; Shi X; Chen W; Pu N; Li W; Li J
    Lipids Health Dis; 2018 Jun; 17(1):144. PubMed ID: 29921298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
    Yu XH; Zhao TQ; Wang L; Liu ZP; Zhang CM; Chen R; Li L; Liu G; Hu WC
    Biochem Biophys Res Commun; 2006 Mar; 341(1):82-7. PubMed ID: 16431216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.
    Ahmad Z; Wilson DP
    J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Characterization of Two Novel Compounds: Heterozygous Variants of
    Wang S; Cheng Y; Shi Y; Zhao W; Gao L; Fang L; Jin X; Han X; Sun Q; Li G; Zhao J; Xu C
    Front Endocrinol (Lausanne); 2022; 13():874608. PubMed ID: 35923617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary hyperchylomicronemia].
    Yamashita S
    Nihon Rinsho; 2013 Sep; 71(9):1578-83. PubMed ID: 24205717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.
    Evans D; Wendt D; Ahle S; Guerra A; Beisiegel U
    Hum Mutat; 1998; 12(3):217. PubMed ID: 10660334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridaemia induced by pregnancy.
    Suga S; Tamasawa N; Kinpara I; Murakami H; Kasai N; Onuma T; Ikeda Y; Takagi A; Suda T
    J Intern Med; 1998 Apr; 243(4):317-21. PubMed ID: 9627147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional characterization of a novel heterozygous missense variant in the LPL associated with recurrent hypertriglyceridemia-induced acute pancreatitis in pregnancy.
    Shi XL; Yang Q; Pu N; Li XY; Chen WW; Zhou J; Li G; Tong ZH; Férec C; Cooper DN; Chen JM; Li WQ
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1048. PubMed ID: 31962008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.
    Kawashiri MA; Higashikata T; Mizuno M; Takata M; Katsuda S; Miwa K; Nozue T; Nohara A; Inazu A; Kobayashi J; Koizumi J; Mabuchi H
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6541-4. PubMed ID: 16174715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
    Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
    J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
    Blackett P; Tryggestad J; Krishnan S; Li S; Xu W; Alaupovic P; Quiroga C; Copeland K
    J Clin Lipidol; 2013; 7(2):132-9. PubMed ID: 23415432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
    N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting APOC3 in the familial chylomicronemia syndrome.
    Gaudet D; Brisson D; Tremblay K; Alexander VJ; Singleton W; Hughes SG; Geary RS; Baker BF; Graham MJ; Crooke RM; Witztum JL
    N Engl J Med; 2014 Dec; 371(23):2200-6. PubMed ID: 25470695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
    Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.